Survey on blood clot prevention after cancer surgery
Part of Cancer, Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study surveys surgeons and surgical advanced practice providers about how they prevent blood clots (deep vein thrombosis) in patients after cancer surgery. It aims to understand current practices and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a surgeon or a surgical advanced practice provider (APP, like a nurse practitioner) who helps care for patients after cancer surgery.
- You work at a site that is part of the NCORP network.
- You perform or help with surgeries for gastrointestinal (e.g., stomach, colon), genitourinary (e.g., bladder, prostate), or gynecologic (e.g., ovarian, uterine) cancers.
- You are willing to complete a short survey about how you prevent blood clots after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people develop blood clots after lung cancer surgery. By tracking your recovery for 30 days, researchers hope to find better ways to predict and prevent clots in the future.
This trial is testing a program to help prevent blood clots in people with cancer who are starting a new type of cancer treatment, like chemotherapy or targeted therapy. The goal is to see if better prevention strategies can keep you safe during treatment.
This trial tests two ways to prevent blood clots (deep vein thrombosis and pulmonary embolism) after colorectal cancer surgery. The study aims to find out if a new method is as good as the standard one, which could help reduce the risk of these serious complications.
This study looks at how people with cancer-related blood clots in the leg or lungs do with anticoagulant (blood thinner) treatment over at least 3 months. It also tracks quality of life and healthcare use, which may help improve supportive care for patients.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
Hear when a new Malignant Digestive System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.